Search Results - Kevin R Kelly

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    DeepDecon accurately estimates cancer cell fractions in bulk RNA-seq data by Jiawei Huang, Yuxuan Du, Andres Stucky, Kevin R. Kelly, Jiang F. Zhong, Fengzhu Sun

    Published in Patterns (2024-05-01)
    Get full text
    Article


  2. 2

    DeepDeconUQ estimates malignant cell fraction prediction intervals in bulk RNA-seq tissue. by Jiawei Huang, Yuxuan Du, Kevin R Kelly, Jinchi Lv, Yingying Fan, Jiang F Zhong, Fengzhu Sun

    Published in PLoS Computational Biology (2025-06-01)
    Get full text
    Article


  3. 3

    CUDC-907 in relapsed/refractory diffuse large B-cell lymphoma, including patients with MYC-alterations: results from an expanded phase I trial by Yasuhiro Oki, Kevin R Kelly, Ian Flinn, Manish R. Patel, Robert Gharavi, Anna Ma, Jefferson Parker, Amir Hafeez, David Tuck, Anas Younes

    Published in Haematologica (2017-11-01)
    Get full text
    Article


  4. 4

    p47phox: A Central Regulator of NADPH Oxidase Function and a Promising Therapeutic Target in Redox-Related Diseases by Madison E. Gamble, Sruthi Sureshkumar, Maria Janina Carrera Espinoza, Natalie L. Hakim, Claudia M. Espitia, Fangchao Bi, Kevin R. Kelly, Wei Wang, Steffan T. Nawrocki, Jennifer S. Carew

    Published in Cells (2025-07-01)
    Get full text
    Article


  5. 5

    Acute myeloid leukemia patients’ clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts by Bernhard Reis, Lori Jukofsky, Gong Chen, Giovanni Martinelli, Hua Zhong, W. Venus So, Michael J. Dickinson, Mark Drummond, Sarit Assouline, Maneja Hashemyan, Michel Theron, Steven Blotner, Je-Hwan Lee, Margaret Kasner, Sung-Soo Yoon, Ruediger Rueger, Karen Seiter, Steven A. Middleton, Kevin R. Kelly, Norbert Vey, Karen Yee, Gwen Nichols, Lin-Chi Chen, William E. Pierceall

    Published in Haematologica (2016-05-01)
    Get full text
    Article


  6. 6

    Phase I study of single-agent CC-292, a highly selective Bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia by Jennifer R. Brown, Wael A. Harb, Brian T. Hill, Janice Gabrilove, Jeff P. Sharman, Marshall T. Schreeder, Paul M. Barr, James M. Foran, Thomas P. Miller, Jan A. Burger, Kevin R. Kelly, Daruka Mahadevan, Shuo Ma, Yan Li, Daniel W. Pierce, Evelyn Barnett, Jeffrey Marine, Monika Miranda, Ada Azaryan, Xujie Yu, Pilar Nava-Parada, Jay Mei, Thomas J. Kipps

    Published in Haematologica (2016-07-01)
    Get full text
    Article


Search Tools: